Brief: Ascelia AB Q3 Operating Loss Of SEK 11.7 Mln

Ascelia Pharma AB

15/05/2019 07:09

May 15 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * FULLY FINANCED PHASE III PROGRAM FOR MANGORAL THROUGH THE
IPO
    * Q3 OPERATING RESULT OF SEK -11.7M (SEK -4.4M)

Source text for Eikon:  ID:nWkrKbNvN 
Further company coverage:  ACELP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))